Comment on FDA approves cure for sickle cell disease, the first treatment to use CRISPR
cynar@lemmy.world 11 months agoThe bigger one is to decouple development from manufacturing.
Development should be done on a bounty type system. Both countries and individual groups can put money into bounties.
Once the bounty is claimed, then the drug is effectively free for all to produce. This lets us leverage capitalism to push prices down.
This would reshape drug development from max money, to most needed.
mapiki@lemm.ee 11 months ago
I like this - but would companies that fail (in being second) not get credit for their work? You could imagine the second place actually having a more effective product at the end.
cynar@lemmy.world 11 months ago
You don’t have a yes/no payout. You have a graded payout. E.g. you might have a 1 shot cure pay out the full amount, but a sustained treatment only pay a smaller %. This lets you encourage development of the most effective treatment, not the most profitable. It’s currently better to make a condition chronic, and so need treatment for a lifetime, than develop a cure.
You also don’t pay out all at once. By spreading it out over sat 10 years. It means it can be adjusted if the company’s claims are… less than accurate.